Skip to content
    GF

    Gates Frontier

    Kirkland, Washington, United StatesFounded 2008

    Gates Frontier is the venture investment arm and family office of Microsoft co-founder Bill Gates, based in Kirkland, Washington. It focuses on frontier and deep technology investments addressing global challenges across AI, climate, energy, life sciences, and advanced hardware.

    Average disclosed round size is $130.9M (across 26 rounds with reported amounts).

    Find people at Gates Frontier on Goldilocks AI

    Portfolio

    17

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    2

    Team

    SF

    Sana Fathima

    Former VC Partner

    BG

    Benjamin Graves

    Investor

    KZ

    Kyle Zabel

    Private Investments

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    28 investments
    CompanyRoundAmountDate
    LLifeMineSeries D$75MSep 2026
    LLifeMineSeries E$188MSep 2026
    LLifeMineSeries E$188MAug 2026
    Neurophos logoNeurophosSeries A$110MJan 2026
    Mainspring Energy, Inc. logoMainspring Energy, Inc.Series F$258MApr 2025
    Lumotive logoLumotiveSeries B$45MFeb 2025
    Lumotive logoLumotiveSeries B—Jan 2025
    MindImmune Therapeutics, Inc. logoMindImmune Therapeutics, Inc.Series A$30MJan 2025
    Mainspring Energy, Inc. logoMainspring Energy, Inc.Series F$258MJan 2025
    CCommonwealth Fusion Systems (CFS)Unknown$863MJan 2025
    LLifeMineSeries D$75MJan 2025
    Cerevance logoCerevanceSeries C$51MApr 2024
    Neurophos logoNeurophosSeed$7.2MDec 2023
    Glydways, Inc. logoGlydways, Inc.Series B$56MOct 2023
    Peregrine Hydrogen logoPeregrine HydrogenSeed$7.8MSep 2023
    Cellares logoCellaresSeries C$255MAug 2023
    Pivotal Commware logoPivotal CommwareSeries D$102MAug 2023
    Imagia logoImagiaSeed$4.5MMay 2023
    Covariant.ai logoCovariant.aiSeries C$80MApr 2023
    Light Field Lab logoLight Field LabSeries B$50MFeb 2023
    Pivotal Commware logoPivotal CommwareSeries D$102MJan 2023
    Neurophos logoNeurophosSeed$7.2MJan 2023
    Synchron logoSynchronSeries C—Dec 2022
    MindImmune Therapeutics, Inc. logoMindImmune Therapeutics, Inc.Series A$30MJun 2022
    MModern ElectronSeries B$30MFeb 2022
    Page 1 of 2

    Top Co-Investors

    Last updated: 7 October 2026